This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
One of the primary themes of the Trump administration is to return power to the states to regulate health-care markets. To that end the Department of Health and Human Services emphasized giving states more flexibility in running the Obamacare exchanges in its first major rulemaking.
Under the so-called payment notice proposed for the 2019 federal HealthCare.gov exchanges used by 39 states, state regulators could choose from a range of options in determining the essential health benefits that individual and small group health plans are required to cover under the Affordable Care Act.
The essential health benefits are patterned after typical employer plans, and include 10 broad categories including outpatient care, hospitalization and emergency services, maternity and pediatric care, prescription drugs, mental health, and preventive services. Most states have chosen the largest small group plan offered in their state as the benchmark on which coverage must be based.
If the proposal is finalized, however, states will be able to choose from plans and categories of coverage offered in other states, or design their own essential health services benefits—as long as the new benefits aren’t more generous than what is currently covered.
Some states may try to redesign benefits to reduce costs and attract more young enrollees, which the exchanges have lagged in doing.
Oklahoma, which earlier this year withdrew its application to make changes to the ACA to reduce premiums in the state, could rethink its plans. “We were prepared at one time to consider many of the changes that are being identified” in the 2019 payment notice, Mike Rhoads, deputy commissioner of life and health insurance in Oklahoma’s Insurance Department, told me.
Prescription drugs may be the most likely category in which states could seek to make changes. Patient groups like The AIDS Institute are worried about that, Deputy Executive Director Carl Schmid told me. “Given this administration, they are all about limiting benefits. We would be very concerned about that,” he said.
The HHS estimates that 10 states a year could take advantage of the plan if it’s finalized.
Read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to books@bna.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to research@bna.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)